RNA therapeutics: Molecular mechanisms, and potential clinical translations

Prog Mol Biol Transl Sci. 2024:203:65-82. doi: 10.1016/bs.pmbts.2023.12.012. Epub 2024 Jan 25.

Abstract

RNA therapies involve the utilization of natural and artificial RNA molecules to control the expression and function of cellular genes and proteins. Initializing from 1990s, RNA therapies now show the rapid growth in the development and application of RNA therapeutics for treating various conditions, especially for undruggable diseases. The outstanding success of recent mRNA vaccines against COVID-19 infection again highlighted the important role of RNA therapies in future medicine. In this review, we will first briefly provide the crucial investigations on RNA therapy, from the first pieces of discovery on RNA molecules to clinical applications of RNA therapeutics. We will then classify the mechanisms of RNA therapeutics from various classes in the treatment of diseases. To emphasize the huge potential of RNA therapies, we also provide the key RNA products that have been on clinical trials or already FDA-approved. With comprehensive knowledge on RNA biology, and the advances in analysis, technology and computer-aid science, RNA therapies can bring a promise to be more expanding to the market in the future.

Keywords: COVID-19; Future medicine; Interference; RNA; Therapeutics; Untreatable disease.

Publication types

  • Review

MeSH terms

  • COVID-19 Vaccines*
  • Humans
  • RNA Interference
  • RNA* / genetics

Substances

  • RNA
  • COVID-19 Vaccines